SITAGLIPTINE ALTER 50 mg, comprimé pelliculé — plaquette(s) PVC PVDC aluminium de 28 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930167410
  • CIP7 3016741
  • CIS 68510974

What the source publishes

Holder
LABORATOIRES ALTER
Active ingredients
SITAGLIPTINE, CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ
Form
comprimé pelliculé
Package
plaquette(s) PVC PVDC aluminium de 28 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2018-12-10
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930167410
{
  "cis": "68510974",
  "cip7": "3016741",
  "form": "comprimé pelliculé",
  "name": "SITAGLIPTINE ALTER 50 mg, comprimé pelliculé — plaquette(s) PVC PVDC aluminium de 28 comprimé(s)",
  "cip13": "3400930167410",
  "holder": "LABORATOIRES ALTER",
  "routes": [
    "orale"
  ],
  "holders": [
    "LABORATOIRES ALTER"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": "9.06",
  "authorisedOn": "2018-12-10",
  "compositions": [
    {
      "name": "SITAGLIPTINE",
      "nature": "FT",
      "strength": "50 mg",
      "linkageNumber": "1",
      "substanceCode": "20740",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ",
      "nature": "SA",
      "strength": "56,685 mg",
      "linkageNumber": "1",
      "substanceCode": "85939",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "8.04",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "SITAGLIPTINE ALTER 50 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) PVC PVDC aluminium de 28 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30 %"
  ],
  "marketingDeclaredOn": "2024-12-31",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "SITAGLIPTINE",
    "CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930167410"